Actualités
Recherche
Infection à HPV, 25 années de recherche
GENESIS - N192 - Novembre/Décembre 2016
Epidémiologie
Int. J. Cancer: 141, 664–670 (2017) VC 2017 International Agency for Research on Cancer (IARC/WHO); licensed by UICC
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Gynecol Oncol (2015)
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial
Dépistage du cancer du col
Évaluation de la recherche des papillomavirus humains (HPV) en dépistage primaire des lésions précancéreuses et cancéreuses du col de l’utérus et de la place du double immuno-marquage p16/Ki67
Haute Autorité de Santé (HAS) juillet 2019
A last screening and remaining lifetime risk of cervical cancer in older, unvaccinated women: a modelling study
The BMJ | BMJ 2010; 340 | doi: 10.1136/BMJ.c1040
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
The BMJ | BMJ 2018;363:k4823 | doi: 10.1136/BMJ.k4823
Dépistage du cancer du col utérin : un tournant ?
GYNÉCOLOGIE OBSTÉTRIQUE PRATIQUE N° 293 • Mars 2017
Nouvelles orientations pour le triage des HPV positifs dans le dépistage du cancer du col utérin, un regard international
GENESIS - N° 192 - Novembre/Décembre 2016
Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India
JNCI, vol 106, Issue 3, March12, 2014
Test HPV et dépistage du cancer du col
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months
American Medical Association - 07/04/2018
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer
American College of Physicians February 8, 2018
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
The BMJ | BMJ 2016;355:i4924 | doi: 10.1136/BMJ.i4924
Le dépistage primaire par test HPV offre une plus grande protection (60-70%) contre le cancer invasif du col que le dépistage par frottis
The Lancet, 2014 ;383, 9916, 524 - 532
Le test HPV dans le dépistage du cancer du col utérin réduit de 70% le cancer invasif comparé au frottis
(4 novembre 2013, The Lancet)
Le test HPV dans le dépistage du cancer du col utérin réduit de 70% le cancer invasif comparé au frottis
(4 novembre 2013, The Lancet)
HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
The BMJ | BMJ 2010;340 | doi : 10.1136/BMJ.c1040
Vaccination HPV
- Published online February 19, 2019
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancerin 181 countries, 2020-99 : a modelling study
2018 by the American College of Obstetricians and Gynecologists
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15–26 Years of Age
PLOS ONE February 14, 2018
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017±2035: Example from Australia
- Published online September 5, 2017
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
- Published online September 5, 2017
Nine-valent human papillomavirus vaccine: great science, but will it save lives?
ANSM/CNAMTS (13/09/2015)
Vaccination contre les infections à HPV et risque de maladies autoimmunes : une étude Cnamts/ANSM rassurante - Point d'information
ANSM/CNAMTS (Rapport final, septembre 2015)
Vaccins anti-HPV et risque de maladies autoimmunes : étude pharmacoépidémiologique
Vaccine (2017) 1729-1732 - Copyright 2017 Published by Elsevier Ltd.
No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in England
Journal of Infectious Diseases Advance Access published (July 30, 2015)
Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs
The New England Journal of Medicine 372;8 nejm.org (February 19, 2015)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
Expert Opin. Drug Saf. (2015) 14(5) (February 24, 2015)
Safety of human papillomavirus vaccines: a review
JAMA. 2015;313(1):54-61. doi:10.1001/jama.2014.16946 (January 6, 2015)
Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
BMJ 2014;348:g1458 doi: 10.1136/bmj.g1458 (Published 4 March 2014)
Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016, VOL. 12, NO. 6, 1406–1417)
Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
Expert Opin. Drug Saf. (2015) 14(5)
Safety of human papillomavirus vaccines: a review
n engl j med 372;8 nejm.org february 19, 2015
HPV “Coverage”
BMJ 2014;348:g1458 doi: 10.1136/Expert Rev. Vaccines Early online, 1–12 (2014)
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon
Décembre 2013
Avis d’experts (Europe et Australie)
Génésis - N°177 Février/mars 2014
Profil de sécurité des vaccins HPV, faut-il s'en inquiéter ?
Springer International Publishing Switzerland 2013
Safety of Human Papillomavirus Vaccines: A Review
(12 décembre 2013, Le Quotidien du Médecin)
Vaccins HPV : que font nos autorités de santé face à la crise ?
Presse Med. 007; 36: 640 - 2007 Elsevier Masson
Prévention du cancer du col utérin (II) : vaccination HPV prophylactique, connaissances actuelles, modalités pratiques et nouveaux enjeux
Presse Med. 2007; 36: 92-111 - 2006 Elsevier Masson
Prévention du cancer du col utérin (I) : apport du dépistage, récents progrès et perspectives
HPV & cancer de la gorge
(Annals of Oncology 00: 1–5, 2017)
Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer
(4 juin 2013, Le Nouvel Observateur)
Cunnilingus et cancer de la gorge : Michael Douglas dit vrai, mais pas d'inquiétude
Que penser du lien établi par Michael Douglas entre sexe oral et cancer de la gorge : l’avis du spécialiste français du papillomavirus - Atlantico
Que penser du lien établi par Michael Douglas entre sexe oral et cancer de la gorge : l’avis du spécialiste français du papillomavirus - Atlantico
Transmission HPV
Lancet Infect Dis 2019; published online, Feb 8
Hand-to-genital and genital-to-genital transmission of human papillomavirus between male and female sexual partners (HITCH): a prospective cohort study
Date de dernière mise à jour : 15/07/2019